67% in study willing to take Covid-19 vaccine, while 20% are neutral
Sign up now: Get ST's newsletters delivered to your inbox

A man getting his Covid-19 vaccination at a centre in Singapore last month. Younger Singaporeans are more likely to be concerned about vaccine safety than those who are older, according to research released yesterday by the Institute of Policy Studies.
PHOTO: REUTERS
Two in three Singaporeans are willing to take the Covid-19 vaccine if it were offered to them, with another one in five neutral about it.
However, about half the population still has concerns about the vaccine's safety and potential side effects, as well as its efficacy.
Among the population, youn-ger Singaporeans are more likely to be concerned about vaccine safety than those who are older, according to research released yesterday by the Institute of Policy Studies (IPS).
These were among the key findings of a working paper released by the think-tank following a year-long study on the attitudes and sentiments of Singaporeans on socioeconomic issues amid the pandemic. The study used data from online surveys conducted over 22 phases, or "waves", from April last year to March this year. Each wave collected responses from more than 500 residents aged 21 years and older.
In the most recent wave last month, IPS found that 67 per cent of respondents were willing to take the vaccine if it were offered to them, with 13 per cent unwilling. The rest were neutral on the issue.
This is an improvement from early February, when 60 per cent said they would take the vaccine, while 20 per cent were unwilling.
About half, or 53 per cent, of respondents said in the latest wave that they still had doubts over vaccine safety, including over potential side effects - though this was an improvement from 63 per cent at the start of this year.
Likewise, half of respondents remained unsure that current vaccines would effectively prevent them from contracting the virus, or were concerned they would be given a vaccine they did not trust - whether it was from Pfizer, Moderna or Sinovac.
More than six in 10 respondents aged 21 to 39 were concerned about the safety and potential side effects of the vaccine, compared with 48 per cent of those aged 60 and above.
IPS Social Lab's research associate Syafiq Suhaini said this could be due to targeted government media campaigns encouraging the elderly to get vaccinated, on top of the "push factor" of increased vulnerability to the virus compared with those who are younger.
The younger generation, on the other hand, has more access and exposure to online news that may highlight possible flaws in today's Covid-19 vaccines.
The Social Lab's associate director Mike Hou suggested that one way to increase vaccine willingness and take-up rate could be to focus public messaging on the vaccine's potential to help life return to normal more quickly.
Social Lab head Mathew Mathews believes confidence levels in vaccines will go up as more people get their jabs. "When your friends and other people tell you about how they have done it, and you don't hear of any real adverse effects, more and more will end up choosing to get vaccinated," he said.


